|
|
Vol. 14.12 – 26 June, 2025
|
|
|
|
|
|
|
|
Investigators showed that epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) enhance the efficacy of TnMUC1 CAR-T cell therapy in EGFR-mutant NSCLC, both in vitro and in vivo. [Cell Reports Medicine]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
The authors reported the direct reprogramming of mouse tail tips and embryonic fibroblasts into induced pulmonary alveolar epithelial-like cells using four transcription factor-coding genes and three-dimensional culture.
[npj Regenerative Medicine]
|
|
|
|
|
|
Utilizing laser capture microdissection coupled to mass spectrometry, researchers investigated the proteomic profiles of airway and alveolar epithelium in non-fibrotic controls and idiopathic pulmonary fibrosis specimens, stratified by the MUC5B promoter variant.
[JCI Insight]
|
|
|
|
|
|
Scientists found that the expression of endogenous serum amyloid A3 was significantly induced in mice with bleomycin-induced fibrosis.
[Acta Pharmacologica Sinica]
|
|
|
|
|
|
|
|
Investigators identified a role of ubiquitin protein ligase E3 component n-recognin 4 (UBR4) in regulating mitochondrial quality, cellular aging, and tumor growth in lung adenocarcinoma.
[Proceedings of The National Academy of Sciences of The United States of America]
|
|
|
|
|
|
Bronchoalveolar lavage fluid samples were collected from 30 NSCLC patients, including 11 patients without metastasis and 19 patients with metastasis. [Journal of Translational Medicine]
|
|
|
|
|
|
|
|
Scientists provide an overview of emerging immunotherapies in clinical development for NSCLC and/or small cell lung cancer, including novel immune-checkpoint modulators, immune cell engagers, adoptive cell therapies, and therapeutic cancer vaccines. [Nature Reviews Clinical Oncology]
|
|
|
|
|
|
|
|
DATROWAY® has been approved in the US for the treatment of adult patients with locally advanced or metastatic EGFR-mutated NSCLC who have received prior EGFR-directed therapy and platinum-based chemotherapy. [Daiichi-Sankyo]
|
|
|
|
|
|
|
|
July 15-17, 2025 Boston, Massachusetts, United States
|
|
|
|
|
|
|
|
|
|
|
Princeton University – Princeton, New Jersey, United States
|
|
|
|
|
|
|
University of Southampton – Southampton, England, United Kingdom
|
|
|
|
|
|
|
CRUK Scotland Institute – Glasgow, Scotland, United Kingdom
|
|
|
|
|
|
|
Carleton University – Ottawa, Ontario, Canada
|
|
|
|
|
|
|
University of Leicester – Leicester, England, United Kingdom
|
|
|
|
|
|